Nassim Usman's Net Worth
$1.22 Million
Who is Nassim Usman?
Nassim Usman has an estimated net worth of $1.22 Million. This is based on reported shares across multiple companies, which include GYRE THERAPEUTICS, INC., Principia Biopharma Inc., and SIRNA THERAPEUTICS INC.
SEC CIK
Nassim Usman's CIK is 0001206872
Past Insider Trading and Trends
2015 was Nassim Usman's most active year for acquiring shares with 10 total transactions. Nassim Usman's most active month to acquire stocks was the month of July. 2019 was Nassim Usman's most active year for disposing of shares, totalling 3 transactions. Nassim Usman's most active month to dispose stocks was the month of March. 2019 saw Nassim Usman paying a total of $52,049.90 for 95,292 shares, this is the most they've acquired in one year. In 2019 Nassim Usman cashed out on 14,529 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GYRE THERAPEUTICS, INC. (GYRE) Snapshot price: $12
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$9.47 | -$17,515.45 | 1.64K |
Jun 28
| |||
Form 4
|
—
|
0
|
$10.53 | -$143,977.00 | 1.64K |
May 1
| |||
Form 4
|
—
|
0
|
$11.54 | -$184,400.00 | 1.64K |
Apr 1
| |||
Form 4
|
—
|
0
|
$12.10 | -$206,600.00 | 1.64K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
| -100.00% | -34.16 |
—
|
—
|
0
|
Aug 31
| |||
Form 4
| +15.26% | 3.25K |
$0.47 | $1,527.50 | 24.54K |
Aug 9
| |||
Form 4
| +18.01% | 3.25K |
$0.46 | $1,495.00 | 21.29K |
Feb 9
| |||
Form 4
| +5.05% | 867 |
$3.62 | $3,138.54 | 18.04K |
Aug 9
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +41.07% | 5K |
$4.63 | $23,150.00 | 17.17K |
Apr 5
| |||
Form 4
| +5.02% | 582 |
$4.81 | $2,799.42 | 12.17K |
Feb 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
| +5.29% | 582 |
$4.81 | $2,799.42 | 11.59K |
Aug 10
| |||
Form 4
| +57.06% | 4K |
$3.91 | $15,647.20 | 11.01K |
Mar 13
| |||
Form 4
| +6.53% | 430 |
$6.23 | $2,678.90 | 7.01K |
Feb 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +6.70% | 413 |
$6.51 | $2,688.63 | 6.58K |
Aug 12
| |||
Form 4
| +43.04% | 4.4K |
$4.63 | $20,372.00 | 14.62K |
May 20 - May 21
| |||
Form 4
| +6.02% | 350 |
$7.04 | $2,464.00 | 6.17K |
Feb 11
| |||
Form 4
| +107.85% | 5.73K |
$4.63 | $26,525.27 | 11.04K |
Jan 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 30
| |||
Form 4
|
—
|
0
|
—
|
—
| 4.14K |
Apr 9
| |||
Form 4
|
∞
| 88 |
$4.63 | $407.44 | 88 |
Apr 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 11
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +5.38% | 4K |
$2.00 | $8,000.00 | 78.38K |
Dec 17
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 22
| |||
Form 4
| +122.23% | 74.38K |
—
|
—
| 135.22K |
Aug 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Principia Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SIRNA THERAPEUTICS INC No price found
Sr VP & Chief Op Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||